Skip to main content
Download PDF

Molecular hydrogen attenuates sepsis-induced cardiomyopathy in mice by promoting autophagy

BMC Anesthesiology volume 24, Article number: 72 (2024) Cite this article

Abstract

Background

Approximately 40 to 60% of patients with sepsis develop sepsis-induced cardiomyopathy (SIC), which is associated with a substantial increase in mortality. We have found that molecular hydrogen (H2) inhalation improved the survival rate and cardiac injury in septic mice. However, the mechanism remains unclear. This study aimed to explore the regulatory mechanism by which hydrogen modulates autophagy and its role in hydrogen protection of SIC.

Methods

Cecal ligation and puncture (CLP) was used to induce sepsis in adult C57BL/6J male mice. The mice were randomly divided into 4 groups: Sham, Sham + 2% hydrogen inhalation (H2), CLP, and CLP + H2 group. The 7-day survival rate was recorded. Myocardial pathological scores were calculated. Myocardial troponin I (cTnI) levels in serum were detected, and the levels of autophagy- and mitophagy-related proteins in myocardial tissue were measured. Another four groups of mice were also studied: CLP, CLP + Bafilomycin A1 (BafA1), CLP + H2, and CLP + H2 + BafA1 group. Mice in the BafA1 group received an intraperitoneal injection of the autophagy inhibitor BafA1 1 mg/kg 1 h after operation. The detection indicators remained the same as before.

Results

The survival rate of septic mice treated with H2 was significantly improved, myocardial tissue inflammation was improved, serum cTnI level was decreased, autophagy flux was increased, and mitophagy protein content was decreased (P < 0.05). Compared to the CLP + H2 group, the CLP + H2 + BafA1 group showed a decrease in autophagy level and 7-day survival rate, an increase in myocardial tissue injury and cTnI level, which reversed the protective effect of hydrogen (P < 0.05).

Conclusion

Hydrogen exerts protective effect against SIC, which may be achieved through the promotion of autophagy and mitophagy.

Peer Review reports

Introduction

Sepsis-induced cardiomyopathy (SIC) is a significant contributor to the poor prognosis of sepsis patients. It has been reported that SIC develops in approximately 40 to 60% of sepsis patients. The mortality rate is around 20% for sepsis patients without SIC, whereas it goes up to 70% for those with SIC [1]. Currently, there is no optimal treatment available for SIC, and understanding its pathogenesis and developing effective treatment strategies remain key challenges in the field of critical care medicine. Most current research focuses on the role of inflammatory mechanisms in sepsis [2, 3]. Autophagy is a lysosome-dependent self-degradation process that plays a crucial role in cell survival. Mitophagy is a form of autophagy, which is a process of selective removal of damaged mitochondria [4]. Autophagy dysfunction has a substantial impact on the pathogenesis of various human diseases, including metabolic diseases, cardiovascular diseases, cancer, sepsis, infectious diseases, and so on [5,6,7]. Several studies have demonstrated the significant role of abnormal autophagy regulation in SIC [8, 9].

In the last decade, molecular hydrogen (H2) has emerged as a promising medical gas with powerful antioxidant and anti-inflammatory properties [10, 11]. Numerous studies have demonstrated the beneficial therapeutic effects of H2 on various diseases, including cardiovascular disease, respiratory disease, infection, and neurodegenerative diseases. However, the exact mechanisms underlying these effects are yet to be fully clarified [12,13,14]. In the case of SIC, our previous research has shown that hydrogen therapy improves the survival rate of sepsis mice and restores cardiac function [11]. Furthermore, several studies have indicated a link between SIC and autophagy. Our previous investigations have revealed that hydrogen can modulate multiple signaling pathways involved in autophagy, endoplasmic reticulum stress, and cellular energy metabolism [15,16,17]. Nevertheless, it remains unclear whether the protective effects of hydrogen on SIC are mediated through autophagy. Therefore, we conducted a study using a mouse model of SIC induced by cecal ligation puncture (CLP) to explore the role of autophagy in the amelioration of SIC by hydrogen therapy.

Materials and methods

Animals

The Laboratory Animal Center of the Chinese Academy of Medical Sciences in Beijing, China, provided us with healthy clean grade male C57BL/6J mice aged 6–8 weeks, weighing 20–25 g. The mice acclimated to the environment for 1 day before the experiment. All the mice were housed at a temperature of 20 to 22 ℃ and a humidity of 60 − 80%, and kept on a 12 h/12 h light/dark cycle, and food and water were available at any time. All the experimental mice were handled humanely. All animal studies were conducted according to the ARRIVE guidelines and approved by the Experimental Animal Ethics Committee of Tianjin Medical University.

Study protocol

This study consists of two experiments.

Experiment 1: Hydrogen promotes autophagy to alleviate cardiomyopathy in septic mice.

Mice were divided into 4 groups by random number method (n = 32/group): Sham, Sham treated with H2 (Sham + H2), CLP, and CLP treated with H2 (CLP + H2). All mice were anesthetized with 2% isoflurane in pure oxygen before CLP procedure. Mice in Sham + H2 group and CLP + H2 group inhaled 2% hydrogen for 1 h at 1 h and 6 h after the operation, meanwhile mice in Sham + H2 group and CLP group inhaled air. Twenty mice were randomly selected from each group to observe the survival rate until 7 days after operation. Six mice in each group were randomly selected and sacrificed 24 h after operation, and their hearts were taken for paraffin section and Hematoxylin-eosin (HE) staining to observe the myocardial histopathological changes. 24 h after operation, 6 mice were randomly selected from each group to test Murine Sepsis Score(MSS) [18]. After the MSS evaluation, isoflurane anesthesia was performed to collect blood samples, and serum cTnI concentration was detected by ELISA. Then hearts of these mice were taken and western blotting was used to detect the expression levels of autophagy related proteins. All experimenters were blinded to the group assignment.

Experiment 2: Autophagy inhibitor BafA1 reverses the protective effect of hydrogen on SIC.

Mice were divided into 4 groups by random number method (n = 32/group): CLP, CLP treated with BafA1 (CLP + BafA1), CLP treated with H2 (CLP + H2), and CLP treated with BafA1 and H2 (CLP + H2 + BafA1). Mice were anesthetized with 2% isoflurane in pure oxygen before CLP procedure. Mice in CLP + H2 group and CLP + H2 + BafA1 group inhaled 2% hydrogen for 1 h at 1 h and 6 h after the operation, meanwhile mice in CLP group and CLP + BafA1 group inhaled air. The autophagy inhibitor Bafilomycin A1 (MCE Company, China) was allocated as a solution with a concentration of 0.25 mg/ml. Mice in CLP + BafA1 group and CLP + H2 + BafA1 group were intraperitoneally injected with BafA1 1 mg/kg 1 h after operation. Meanwhile mice in CLP group and CLP + H2 group were injected with equal dose of normal saline. Twenty mice were randomly selected from each group to observe the survival rate until 7 days after operation. Six mice in each group were randomly selected and sacrificed 24 h after operation, and their hearts were taken for paraffin section and haematoxylin-eosin (HE) staining to observe the myocardial histopathological changes. 24 h after operation, 6 mice were randomly selected from each group to test Murine Sepsis Score(MSS). After the MSS evaluation, isoflurane anesthesia was performed to collect blood samples, and serum cTnI concentration was detected by ELISA. Then hearts of these mice were taken and western blotting was used to detect the expression levels of autophagy related proteins. All experimenters were blinded to the group assignment.

SIC model

SIC model in mice was induced by CLP. Mice were placed supine on a clean operating surface after 2% isoflurane anesthesia. Abdominal hair was removed and the skin was disinfected with iodor. A 1 cm longitudinal midline incision was made. The cecum was explored with smooth forceps. Mouse model with moderate sepsis: 60% of the cecum was ligated with surgical sutures, followed by two punctures with a 22-gauge needle at the midpoint of the caudal end of cecum ligation. After manually extruding part of the intestinal content, the cecum was returned to the abdominal cavity and the abdominal tissues were sutured layer by layer with a 3–0 surgical suture. Cecal exploration operation was performed in Sham group and Sham + H2 group, but no cecal ligation or perforation. The mice were resuscitated after subcutaneous injection of 0.9% sodium chloride solution 1 ml/20 g liquid into the neck, then placed on warm blankets until they woke up and returned to their cages. The antibiotic meropenem 20 mg/kg was injected intraperitoneally 6 h after operation.

2% H2 treatment

Hydrogen gas was prepared using a hydrogen generator (model AMS-H-03; Asclepius Meditec Co., Ltd., Shanghai, China). The mice were put into a sealed plexiglass chamber with an air outlet and an air inlet, and the hydrogen concentration was adjusted to 2% by mixing hydrogen with air. PG610 hydrogen concentration detector (Yingte electrical equipment Co., LTD, Henan, China) was used to measure the hydrogen concentration at 2%, and ST8100A oxygen detector (Smart Sensor, Kuangdong, China) was used at the same time, the oxygen concentration was 20.9%.

Myocardial pathology assessment

Myocardial pathology was assessed by the HE staining method. Under deep anesthesia, the exposed mouse hearts were first injected with normal saline and then 4% paraformaldehyde. Mice heart tissues were taken, fixed in 4% paraformaldehyde solution, embedded in paraffin, and cut into 5 μm thick sections. Samples were dewaxed before HE staining and then stained. Based on previous studies [19], two pathologists, who were unaware of the experiment, scored myocardial pathological changes under the microscope BX51 (Olympus Corporation, Tokyo, Japan) based on the percentage of cells that showed myofibrillar loss or cytoplasmic vacuolation: 0 = no damage, 1 = < 5%, 2 = 5–30%, 3 = > 30%.

Enzyme-linked immunosorbent assay (ELISA)

24 h after operation, 6 mice in each group were randomly collected and blood samples were collected under sevoflurane anesthesia. These blood samples were left at room temperature for 30 min, centrifuged at 3000 RPM for 10 min, and then the supernatant was collected. According to the manufacturer’s instructions, the serum cTnI concentration was detected using mouse ELISA kit (Elabscience Biotechnology Co., LTD., Wuhan, China).

Western blotting analysis

After blood collection, mice were sacrificed under deep anesthesia, the whole heart was taken, and the atrium was cut off. The tissues were weighed, RIPA lysis buffer and protease inhibitor were added, ground on ice and crushed by an ultrasonic cell crusher (Xinzhi Biotechnology Co., Ltd., Ningbo, China), then supernatant was obtained. The protein concentration was determined using the BCA Protein Assay Kit (Biosharp Co., Ltd.). Loading buffer (Biosharp Co., Ltd.) was added, boiled for 10 min and cooled to room temperature. Electrophoresis was performed using 8-16% and 10% gel, and transferred to polyvinylidene fluoride (PVDF) membranes (0.45 μm, Millipore Co., Ltd.). The membranes were then blocked by incubation in 10% nonfat milk at room temperature for 1.5 h, then incubated with primary antibodies at 4 ℃ overnight and incubated with secondary antibodies at room temperature for 1 h. The protein bands were then visualised by ECL development and exposure (ProteinSample, USA). The primary antibodies used were anti-LC3B (1:2000, Abcam, USA), anti-P62 (1:500, Abcam, USA), anti-PINK1 (1:200, Abcam, USA), anti-Parkin (1:2000, Abcam, USA), and anti-GAPDH (1:5000, Affinity Biosciences, USA). The secondary antibodies used were goat anti-rabbit (1:5000, Affinity Biosciences, USA) and goat anti-mouse (1:5000, Aorui Dongyuan Biotechnology Co., LTD., Wuxi, China). The protein bands exposure instrument (Proteinsimple, FluorChem, USA) could only expose the protein bands, and could not take photos and synthesize the whole protein membrane in advance. The protein bands provided in this paper were all cropped protein bands. The gray values of the bands were quantified by ImageJ software, and the expression levels of target proteins were standardised with GAPDH level.

Statistical analysis

SPSS26.0 software was used for analysis. The survival rate of each group was expressed as percentage (%), and the measurement data of normal distribution were expressed as mean ± standard deviation (x ± s). One-way ANOVA was used for comparison between groups, and Fisher exact probability method was used for comparison of survival rates. P < 0.05 was considered statistically significant.

Results

H2 inhalation improves the survival rates of septic mice and murine Sepsis score

The 7-day survival rate of mice is shown in Table 1, and the 7-day survival curve is shown in Fig. 1. As shown in Fig. 1A, the 7-day survival rates of both the Sham group and Sham + H2 group were both 100%, with no statistical significance (P > 0.05). However, compared to the Sham group, the 7-day survival rates for the CLP group and CLP + H2 group were 40% (P < 0.05) and 75% (P < 0.05), respectively. Mice in the CLP group showed obvious mental fatigue, drowsiness, less movement, purulent secretion in the corner of the eyes, and coarse and dull hair. Therefore, we tested the murine sepsis score (MSS). As shown in Fig. 1B, compared with the Sham group, the MSS of the CLP group was significantly increased (P < 0.05), and the MSS was obviously decreased after H2 treatment (P < 0.05).

Table 1 The effect of H2 on the survival rate of mice (%)
Full size table
Fig. 1
figure 1

2% H2 inhalation elevated the 7-day survival rate of the septic mice and alleviated myocardial injury. (A) The 7-day survival rate (n = 20, log-rank test), *P < 0.05 vs. Sham group, #P < 0.05 vs. CLP group. (B) Murine Sepsis Score (n = 6), (C) Serum cTnI level (n = 6), (D) HE staining of mouse myocardial tissue (×40) (n =6), and (E) the myocardial pathological score (n = 6) were measured in each group. *P < 0.05

Full size image

H2 inhalation alleviates pathological changes and serum markers of SIC

The serum cTnI levels in each group were detected 24 h after operation. Compared to the Sham group, cTnI levels were elevated 24 h after the operation in both the CLP group and CLP + H2 group (P < 0.05). Compared to the CLP group, cTnI level in the CLP + H2 group was decreased (P < 0.05) (Fig. 1C).

Twenty-four hours after the operation, myocardial fibers in the Sham group and Sham + H2 group were observed under a high-power light microscope, revealing closely arranged and well-structured fibers. Compared with the Sham group, the myocardial fibers in the CLP group exhibited evident edema, disordered, broken and vacuolated, accompanied by infiltration of inflammatory cells and overflow of red blood cells. As shown in Fig. 1C, compared with the CLP group, the arrangement of myocardial fibers in the CLP + H2 group appeared more regular, with slight cellular edema, reduced fiber rupture and cytoplasmic vacuolation, and a small amount of inflammatory cell infiltration (Fig. 1D). Furthermore, following the aforementioned methodology, the myocardial pathological scores in the CLP + H2 group were significantly higher than those in the CLP group (P < 0.05) (Fig. 1E).

H2 inhalation affects autophagy in septic mice

Western Blot was used to detect the expression levels of autophagy-related proteins. We found that compared to the Sham group, there was no significant change in the LC3II/LC3I ratio within the CLP group. However, the levels of P62 protein and phosphatase and tensin homolog (PTEN) induced putative kinase 1 (PINK1)/Parkin were both significant increased (P < 0.05). On the other hand, in the CLP + H2 group, the LC3II/LC3I ratio was increased, while the levels of P62 and PINK1/Parkin were both decreased when compared to the CLP group, and all of these differences were statistically significant (P < 0.05) (Fig. 2A-E).

Fig. 2
figure 2

Effects of 2% hydrogen on myocardial autophagy and mitophagy in septic mice. (A-E) Expression levels of autophagy- and mitophagy-related proteins (n = 6). The data are expressed as mean ± SD. *P < 0.05

Full size image

BafA1 significantly inhibits autophagy in septic mice

The autophagy levels in myocardial tissue were detected 24 h after operation by western blotting. As shown in Fig. 3A-C, we observed that, in comparison to the CLP group, there was a decrease in the LC3II/LC3I ratio and an increase in P62 level in the CLP + BafA1 group (P < 0.05). Furthermore, compared to the CLP + H2 group, there was a decrease in the LC3II/LC3I ratio and an increase in P62 level in the CLP + H2 + BafA1 group (P < 0.05).

Fig. 3
figure 3

BafA1 significantly inhibits myocardial autophagy in septic mice. (A-C) Expression levels of autophagy-related proteins (n = 6). The data are expressed as mean ± SD. *P < 0.05

Full size image

BafA1 reduces the survival rate of septic mice and murine sepsis score

As shown in Fig. 4A, the 7-day survival rates in the CLP, CLP + BafA1, CLP + H2, and CLP + H2 + BafA1 groups were 35% (7/20), 30% (6/20), 70% (14/20), and 30% (6/20), respectively. There was no significant difference between the CLP group and CLP + BafA1 group (P > 0.05). Compared with CLP group, the 7-day survival rate in the CLP + H2 group was improved (P < 0.05). Compared with CLP + H2 group, the 7-day survival rate in the CLP + H2 + BafA1 group was lower (P < 0.05). The 7-day survival rate of mice is shown in Table 2. In addition, compared with the CLP group, MSS was significantly improved after H2 inhalation (P < 0.05). However, the MSS of the CLP + H2 group increased again after BafA1 used (P < 0.05), which were shown in Fig. 4B.

Fig. 4
figure 4

Effects of BafA1 on the 7-day survival rate and myocardial injury in septic mice. (A) The 7-day survival rate (n = 20, log-rank test), #P < 0.05 vs. CLP group, &P < 0.05 vs. CLP + H2 group. (B) Murine Sepsis Score (n = 6), (C) Serum cTnI level (n = 6), (D) HE staining of mouse myocardial tissue (×40) (n = 6), and (E) the myocardial pathological score (n = 6) were measured in each group. *P < 0.05

Full size image
Table 2 The effect of BafA1 on the survival rate of mice (%)
Full size table

BafA1 increases pathological changes and elevates serum markers of SIC

Myocardial tissue was observed by HE staining under a high-power light microscope. 24 h after operation, the CLP + H2 + BafA1 group exhibited more obvious myocardial tissue cell edema, an increased ratio of cytoplasmic vacuolation, and elevated interstitial inflammatory cell infiltration when compared to the CLP + H2 group. This indicated aggravated inflammation and evident injury in the myocardium. Moreover, both the pathological score and cTnI content were significantly increased (P<0.05) (Fig. 4C-E).

Discussion

In this study, we found that inhalation of 2% hydrogen can improve the survival rate of sepsis mice, alleviate myocardial pathological injury, and reduce serum marker of SIC. This beneficial effect was achieved by promoting both autophagy and mitophagy in cardiomyocyte. Notably, when an autophagy inhibitor was added, it reversed the protective effects of hydrogen in SIC, underscoring the important role of autophagy in mediating these effects.

Cardiac dysfunction caused by sepsis is a crucial part of multiple organ failure in sepsis, contributing to a relatively high mortality rate [20]. The 7-day mortality rate of the CLP mouse model established in this study was 60%, which is consistent with previous studies [21]. Hydrogen, as a novel medical gas molecule, has been confirmed to possess anti-inflammatory and antioxidant properties. Numerous studies have demonstrated its effectiveness in mitigating functional damage in organs such as the brain, lungs, and intestines during sepsis [22,23,24]. With reference to literature, the concentration of troponin I (cTnI) in serum was employed as a marker to evaluate myocardial injury in sepsis [25]. The findings of this study revealed that inhalation of 2% hydrogen at 1 and 6 h respectively after CLP surgery significantly improved the 7-day survival rate of mice, alleviated myocardial tissue edema and inflammatory cell infiltration, and decreased the serum marker of SIC. The above results confirmed the therapeutic potential of hydrogen in alleviating myocardial injury, which was consistent with previous studies [11, 26].

The pathogenesis of SIC is complex, mainly involving inflammatory mediators disorders, mitochondrial dysfunction, autophagy dysregulation, oxidative stress, calcium regulation disorders, endothelial dysfunction, etc. [1, 27, 28]. . Numerous studies have recognized the critical role of autophagy regulation in SIC [8, 27]. In sepsis, there is an upregulation of autophagy activity in myocardial tissue, aiding in the clearance of pathogens and damaged organelles [29]. A recent study showed that blocking the mTOR pathway accelerated autophagy, leading to a protective effect against CLP-induced SIC [30]. Another study revealed that enhancing AMPK expression improved myocardial systolic function in septic mice by increasing autophagy activity [31]. Mitophagy, a specialized type of autophagy, selectively eliminates excess or damaged mitochondria to maintain mitochondrial quantity and function stability [32]. Given that cardiomyocytes, with their high energy demands, heavily rely on ATP generated by mitochondria for normal function, impaired mitochondrial function poses a fatal threat to the septic heart, and mitophagy serves as an essential self-repair pathway [33]. Yue Wang et al. found that down-regulating myocardial mitochondrial autophagy in SIC mice led to reduced ATP production levels in cardiomyocytes and increase myocardial damage [34].

In this study, with reference to literature, autophagy activity in septic myocardial tissue was assessed by measuring the levels of LC3-II/I and P62 protein, while mitochondrial autophagy activity was evaluated by detecting PINK1/Parkin levels. LC3 (microtubule-associated protein 1 light chain 3, LC3) is a membrane protein located on the autophagosome. LC3-I is synthesized immediately after autophagy initiation, and it subsequently transforms into mature LC3-II through binding to autophagy proteins. Mature LC3-II is located on the fully formed autophagosome. Therefore, LC3-II/I level reflects the progression of autophagy and serves as a reliable indicator of autophagy activity. An increase in just LC3-II content cannot solely represent the upregulation of autophagy activity, which may be due to the inability of autophagosome to fuse with lysosome and undergo degradation, resulting in a state of accumulation [35]. Another commonly used marker to assess autophagy activity is the P62 protein. P62 is degraded via autophagy, and its content exhibits a negative correlation with autophagy activity, that is, P62 accumulates upon autophagy inhibition and decreases upon autophagy induction [36]. Mitophagy mainly encompasses three pathways: PINK1/Parkin, BNIP3, and FUNDC1 [37]. The PINK1/Parkin pathway plays a central role in the ubiquitination process, becoming activated when changes occur in mitochondrial membrane potential following mitochondrial damage. Upon activation, PINK1/Parkin is transferred to the outer membrane of mitochondria, where it is recognized by autophagosomes and subsequently transported to lysosomes through phagocytosis [38]. Our findings demonstrated that in the myocardial tissue of the CLP group, there was no statistically significant difference in the ratio of LC3-II/I compared to the Sham group. However, the content of P62 protein showed a significant increase, indicating a blockade in autophagy flux. Both PINK1 and Parkin expressions were elevated, suggesting increased mitophagy or protein accumulation caused by the obstruction of autophagy. In the CLP + H2 group, compared to the CLP group, the ratio of LC3-II/I was significantly increased, while P62 content decreased, indicating that hydrogen could promote autophagy. However, both PINK1 and Parkin levels decreased, suggesting that the upregulation of mitophagy protein at 24 h after CLP might be caused by protein accumulation due to the restriction of mitophagy, and hydrogen promoted the sustained progression of mitophagy. These results suggest that hydrogen may alleviate SIC by enhancing autophagy and mitophagy processes.

Autophagy is a complex and dynamic multi-step process. During different stages of sepsis, autophagy activity changes constantly [39]. Studies have demonstrated that the application of rapamycin can induce complete myocardial autophagy process in sepsis, leading to reduced myocardial inflammatory response and improved cardiac function. Conversely, the use of the autophagy inhibitor BafA1 did not yield any benefits [40]. In our study, we observed that hydrogen therapy can significantly increase the LC3-II/LC3-I ratio and decrease the level of autophagy substrate P62. Hence, we hypothesized that hydrogen may promote the continuation of late-stage autophagy, that is, the binding and degradation process of autophagosomes and lysosomes. To validate this hypothesis, we used the late-stage autophagy inhibitor BafA1, which inhibits autophagolysosomes acidification by blocking V-ATPase [41]. The results showed that BafA1 treatment significantly inhibited autophagy, as evidenced by a decrease in the LC3-II/LC3-I ratio and an increase in P62 expression. Furthermore, when autophagy was blocked, myocardial damage was also aggravated. These findings suggested that BafA1 reversed the myocardial protective effect of hydrogen by blocking autophagy.

Hydrogen, as a gas with anti-inflammatory and antioxidant properties, has the potential to alleviate the systemic inflammatory response in sepsis, reduce tissue and blood levels of inflammatory factors, and modulate macrophage function [12, 14]. Additionally, hydrogen can interact with oxygen free radicals, thereby reducing oxidative stress in the body [10]. Consequently, we hypothesized that hydrogen could mitigate the dysregulation of autophagy in septic myocardial cells by alleviating excessive inflammatory responses and oxidative stress. Previous studies have demonstrated that hydrogen can protect against sepsis-induced damage in the brain, lungs, nerves, and other tissues by regulating autophagy activity. However, no studies have explored whether hydrogen can safeguard the myocardium from sepsis-induced damage through autophagy.

There are some limitations in our study. We have only confirmed the association between the protective effect of hydrogen on SIC and its promotion of autophagy and mitophagy. However, we have to identify the specific signaling pathway through which hydrogen regulates autophagy to exert its protective effects on SIC. Future studies should focus on elucidating the precise target of hydrogen in autophagy initiation and autophagosomal formation, so as to lay an experimental foundation for uncovering novel mechanisms for SIC therapy.

Conclusion

In conclusion, our study demonstrates that hydrogen can improve the 7-day survival rate of septic mice and ameliorate myocardial injury by promoting autophagy and mitophagy. These findings offer a novel therapeutic approach for the treatment of SIC.

Data availability

The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.

Abbreviations

SIC:

sepsis-induced cardiomyopathy

H2 :

molecular hydrogen

CLP:

cecal ligation and puncture

HE:

hematorylin-eosin

ELISA:

enzyme-linked immunosorbent assay

References

  1. Martin L, Derwall M, Al ZS, Zechendorf E, Reuter DA, Thiemermann C, Schuerholz T. The Septic Heart: current understanding of Molecular mechanisms and clinical implications. CHEST 2019, 155(2):427–37.

  2. Qiu J, Xiao X, Gao X, Zhang Y. Ulinastatin protects against sepsis–induced myocardial injury by inhibiting NLRP3 inflammasome activation. MOL MED REP 2021, 24(4).

  3. Jiang Y, Li Y, Zhang Y, Hu D, Zhang S, Wang C, Huang S, Zhang A, Jia Z, You R. NSC228155 alleviates septic cardiomyopathy via protecting mitochondria and inhibiting inflammation. INT IMMUNOPHARMACOL. 2023;116:109847.

    Article  CAS  PubMed  Google Scholar 

  4. Li A, Gao M, Liu B, Qin Y, Chen L, Liu H, Wu H, Gong G. Mitochondrial autophagy: molecular mechanisms and implications for cardiovascular disease. CELL DEATH DIS. 2022;13(5):444.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Mizushima N, Levine B. Autophagy in Human diseases. NEW ENGL J MED. 2020;383(16):1564–76.

    Article  CAS  PubMed  Google Scholar 

  6. Hampton T. Autophagy genes linked to Sepsis Survival in mice. JAMA-J AM MED ASSOC. 2019;322(13):1244–5.

    Article  Google Scholar 

  7. Hoshino A, Wang WJ, Wada S, McDermott-Roe C, Evans CS, Gosis B, Morley MP, Rathi KS, Li J, Li K, et al. The ADP/ATP translocase drives mitophagy independent of nucleotide exchange. Nature. 2019;575(7782):375–9.

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  8. Sun Y, Cai Y, Zang QS. Cardiac Autophagy in Sepsis. CELLS-BASEL 2019, 8(2).

  9. Zhu CL, Yao RQ, Li LX, Li P, Xie J, Wang JF, Deng XM. Mechanism of Mitophagy and its role in Sepsis Induced Organ Dysfunction: a review. FRONT CELL DEV BIOL. 2021;9:664896.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Tian Y, Zhang Y, Wang Y, Chen Y, Fan W, Zhou J, Qiao J, Wei Y. Hydrogen, a Novel Therapeutic Molecule, regulates oxidative stress, inflammation, and apoptosis. FRONT PHYSIOL. 2021;12:789507.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Zhang Y, Dong A, Xie K, Yu Y. Protective Effects of Hydrogen on Myocardial Mitochondrial Functions in Septic Mice. BIOMED RES INT 2020, 2020:1568209.

  12. Yang M, Dong Y, He Q, Zhu P, Zhuang Q, Shen J, Zhang X, Zhao M. Hydrogen: A Novel Option in Human Disease Treatment. OXID MED CELL LONGEV 2020, 2020:8384742.

  13. Saengsin K, Sittiwangkul R, Chattipakorn SC, Chattipakorn N. Hydrogen therapy as a potential therapeutic intervention in heart disease: from the past evidence to future application. CELL MOL LIFE SCI. 2023;80(6):174.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Wu C, Zou P, Feng S, Zhu L, Li F, Liu TC, Duan R, Yang L. Molecular hydrogen: an emerging Therapeutic Medical Gas for Brain disorders. MOL NEUROBIOL. 2023;60(4):1749–65.

    Article  CAS  PubMed  Google Scholar 

  15. Chen H, Mao X, Meng X, Li Y, Feng J, Zhang L, Zhang Y, Wang Y, Yu Y, Xie K. Hydrogen alleviates mitochondrial dysfunction and organ damage via autophagy–mediated NLRP3 inflammasome inactivation in sepsis. INT J MOL MED. 2019;44(4):1309–24.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Chen HG, Han HZ, Li Y, Yu YH, Xie KL. Hydrogen alleviated organ injury and dysfunction in sepsis: the role of cross-talk between autophagy and endoplasmic reticulum stress: experimental research. INT IMMUNOPHARMACOL. 2020;78:106049.

    Article  CAS  PubMed  Google Scholar 

  17. Bai Y, Han Q, Dong B, Lin H, Jiang Y, Zhang X, Chen H, Yu Y. PPARalpha contributes to the therapeutic effect of hydrogen gas against sepsis-associated encephalopathy with the regulation to the CREB-BDNF signaling pathway and hippocampal neuron plasticity-related gene expression. BRAIN RES BULL. 2022;184:56–67.

    Article  CAS  PubMed  Google Scholar 

  18. Shrum B, Anantha RV, Xu SX, Donnelly M, Haeryfar SM, McCormick JK, Mele T. A robust scoring system to evaluate sepsis severity in an animal model. BMC RES NOTES. 2014;7:233.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Guo R, Hua Y, Ren J, Bornfeldt KE, Nair S. Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity. CELL DEATH DIS. 2018;9(6):692.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Lin Y, Xu Y, Zhang Z. Sepsis-Induced Myocardial Dysfunction (SIMD): the pathophysiological mechanisms and therapeutic strategies targeting Mitochondria. INFLAMMATION. 2020;43(4):1184–200.

    Article  CAS  PubMed  Google Scholar 

  21. Vieira BM, Caetano M, de Carvalho MT, Dos SAF, Tome FD, de Oliveira JF, Soave DF, Pereira JX, Celes M. Impacts of Curcumin Treatment on Experimental Sepsis: A Systematic Review. OXID MED CELL LONGEV 2023, 2023:2252213.

  22. Chen H, Lin H, Dong B, Wang Y, Yu Y, Xie K. Hydrogen alleviates cell damage and acute lung injury in sepsis via PINK1/Parkin-mediated mitophagy. INFLAMM RES. 2021;70(8):915–30.

    Article  CAS  PubMed  Google Scholar 

  23. Qi B, Song Y, Chen C, Zhao L, Ma W, Meng S, Zhuang X, Lin H, Liang J, Cui Y, et al. Molecular hydrogen attenuates sepsis-induced cognitive dysfunction through regulation of tau phosphorylation. INT IMMUNOPHARMACOL. 2023;114:109603.

    Article  CAS  PubMed  Google Scholar 

  24. Ikeda M, Shimizu K, Ogura H, Kurakawa T, Umemoto E, Motooka D, Nakamura S, Ichimaru N, Takeda K, Takahara S, et al. Hydrogen-rich saline regulates intestinal barrier dysfunction, dysbiosis, and bacterial translocation in a murine model of Sepsis. SHOCK. 2018;50(6):640–7.

    Article  CAS  PubMed  Google Scholar 

  25. Forner J, Schupp T, Weidner K, Rusnak J, Jawhar S, Dulatahu F, Bruck LM, Behnes M, Hoffmann U, Bertsch T et al. Cardiac Troponin I Reveals Diagnostic and Prognostic Superiority to Aminoterminal Pro-B-Type Natriuretic Peptide in Sepsis and Septic Shock. J CLIN MED : 2022, 11(21).

  26. Nie C, Ding X, Zheng AR, Li M, Pan Z, Yang S. Hydrogen gas inhalation alleviates myocardial ischemia-reperfusion injury by the inhibition of oxidative stress and NLRP3-mediated pyroptosis in rats. LIFE SCI. 2021;272:119248.

    Article  CAS  PubMed  Google Scholar 

  27. Yang H, Zhang Z. Sepsis-induced myocardial dysfunction: the role of mitochondrial dysfunction. INFLAMM RES. 2021;70(4):379–87.

    Article  CAS  PubMed  Google Scholar 

  28. Zhang G, Dong D, Wan X, Zhang Y. Cardiomyocyte death in sepsis: mechanisms and regulation (review). MOL MED REP 2022, 26(2).

  29. Sun Y, Yao X, Zhang QJ, Zhu M, Liu ZP, Ci B, Xie Y, Carlson D, Rothermel BA, Sun Y et al. Beclin-1-Dependent Autophagy Protects the Heart During Sepsis. CIRCULATION : 2018, 138(20):2247–2262.

  30. Han W, Wang H, Su L, Long Y, Cui N, Liu D. Inhibition of the mTOR Pathway Exerts Cardioprotective Effects Partly through Autophagy in CLP Rats. MEDIAT INFLAMM 2018, 2018:4798209.

  31. Zhang J, Zhao P, Quan N, Wang L, Chen X, Cates C, Rousselle T, Li J. The endotoxemia cardiac dysfunction is attenuated by AMPK/mTOR signaling pathway regulating autophagy. BIOCHEM BIOPH RES CO. 2017;492(3):520–7.

    Article  CAS  Google Scholar 

  32. Ajoolabady A, Chiong M, Lavandero S, Klionsky DJ, Ren J. Mitophagy in cardiovascular diseases: molecular mechanisms, pathogenesis, and treatment. TRENDS MOL MED. 2022;28(10):836–49.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Scheffer D, Garcia AA, Lee L, Mochly-Rosen D, Ferreira J. Mitochondrial Fusion, Fission, and Mitophagy in Cardiac diseases: challenges and Therapeutic opportunities. ANTIOXID REDOX SIGN. 2022;36(13–15):844–63.

    Article  CAS  Google Scholar 

  34. Wang Y, Jasper H, Toan S, Muid D, Chang X, Zhou H. Mitophagy coordinates the mitochondrial unfolded protein response to attenuate inflammation-mediated myocardial injury. REDOX BIOL. 2021;45:102049.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Jiang P, Mizushima N. LC3- and p62-based biochemical methods for the analysis of autophagy progression in mammalian cells. Methods. 2015;75:13–8.

    Article  CAS  PubMed  Google Scholar 

  36. Danieli A, Martens S. p62-mediated phase separation at the intersection of the ubiquitin-proteasome system and autophagy. J CELL SCI 2018, 131(19).

  37. Belousov DM, Mikhaylenko EV, Somasundaram SG, Kirkland CE, Aliev G. The Dawn of Mitophagy: what do we know by now? CURR NEUROPHARMACOL. 2021;19(2):170–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Wu Y, Jiang T, Hua J, Xiong Z, Dai K, Chen H, Li L, Peng J, Peng X, Zheng Z, et al. PINK1/Parkin-mediated mitophagy in cardiovascular disease: from pathogenesis to novel therapy. INT J CARDIOL. 2022;361:61–9.

    Article  PubMed  Google Scholar 

  39. Yin X, Xin H, Mao S, Wu G, Guo L. The role of Autophagy in Sepsis: Protection and Injury to organs. FRONT PHYSIOL. 2019;10:1071.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Hsieh CH, Pai PY, Hsueh HW, Yuan SS, Hsieh YC. Complete induction of autophagy is essential for cardioprotection in sepsis. ANN SURG. 2011;253(6):1190–200.

    Article  PubMed  Google Scholar 

  41. Raudenska M, Balvan J, Masarik M. Crosstalk between autophagy inhibitors and endosome-related secretory pathways: a challenge for autophagy-based treatment of solid cancers. MOL CANCER. 2021;20(1):140.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This study was supported by a grant from the research project of Tianjin Municipal Education Commission (2022KJ193 to Yan Cui), National Natural Science Foundation of China (81971879 to Keliang Xie), Beijing, China, and Tianjin Medical University General Hospital Clinical Research Program (22ZYYLCCG05 to Keliang Xie), and 2021-N-15 project of China International Medical Foundation (2021-N-15-8 to Keliang Xie).

Author information

Authors and Affiliations

  1. Department of Pathogen Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, 300070, China

    Yan Cui

  2. Department of Anesthesiology, Tianjin Institute of Anesthesiology, Tianjin Medical University General Hospital, No. 154, Anshan Road, Heping District, Tianjin, 300052, China

    Yingning Li, Shuqi Meng & Keliang Xie

  3. Department of Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin, 300052, China

    Shuqi Meng, Yu Song & Keliang Xie

Authors
  1. Yan Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yingning Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shuqi Meng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yu Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Keliang Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Y.C. designed the study, analyzed it, wrote the main manuscript text, and acquired funding. YN.L. acquired the data and analyzed it. QS.M. analyzed the data and modified the manuscript. Y.S. analyzed the data. KL.X. revised the paper, made the final version, and acquired funding. All authors reviewed the manuscript.

Corresponding author

Correspondence to Keliang Xie.

Ethics declarations

Ethic approval and consent to participate

This study was approved by the Animal Ethics Committee of the Tianjin Medical University General Hospital with approval number [IRB2022-DWFL-587].

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cui, Y., Li, Y., Meng, S. et al. Molecular hydrogen attenuates sepsis-induced cardiomyopathy in mice by promoting autophagy. BMC Anesthesiol 24, 72 (2024). https://0-doi-org.brum.beds.ac.uk/10.1186/s12871-024-02462-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s12871-024-02462-4

Keywords

BMC Anesthesiology

ISSN: 1471-2253

Contact us